Immune checkpoint inhibitor‐induced acquired haemophilia: A pharmacovigilance analysis of the FDA adverse event reporting system-Reference-Cited by-同舟云学术

Immune checkpoint inhibitor‐induced acquired haemophilia: A pharmacovigilance analysis of the FDA adverse event reporting system

Author:

Moore Donald C.¹^ORCID,Elmes Joseph B.²,Arnall Justin R.³^ORCID,Strassels Scott A.⁴,Patel Jai N.⁵

Affiliation:

1. Atrium Health, Department of Pharmacy Levine Cancer Institute Charlotte North Carolina USA

2. Atrium Health, Department of Pharmacy Levine Cancer Institute Concord North Carolina USA

3. Atrium Health Specialty Pharmacy Service Charlotte North Carolina USA

4. Department of Pharmacy Atrium Health Charlotte North Carolina USA

5. Atrium Health, Department of Cancer Pharmacology and Pharmacogenomics Levine Cancer Institute Charlotte North Carolina USA

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

Reference12 articles.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献